ASAM Debuts Patient Placement Criteria Products

David Mee-Lee, M.D.

David Mee-Lee, M.D.

ASAM’s recent success in advancing the use and understanding of its Patient Placement Criteria through a new strategic partnership benefits addiction professionals and clinicians alike. In fact, when ASAM and The Change Companies partnered last fall, ASAM made huge strides in expanding access to and improving the quality of addiction treatment by introducing a host of new assessment tools and treatment guides.

Likewise, The Change Companies, with its expertise in international publishing, consulting, training, and multimedia, brings to the partnership a rich history of work with experts in the field of behavior change to develop effective and evidence-based prevention, treatment, and recovery resources. Together, the two have introduced a new level of support resources designed to aid clinical decision making for addiction treatment.

Paul Earley, M.D., FASAM

Paul Earley, M.D., FASAM

“The interactive journals and eLearning courses we created as a result of this partnership are designed to make it easy to implement ASAM’s Patient Placement Criteria for addiction assessment and treatment, even for those professionals who are outside the addiction treatment field,” says David Mee-Lee, M.D., Senior Vice President of The Change Companies and editor of the ASAM Patient Placement Criteria. “The result is an array of resources now available to professionals that combines the assessment, service planning, and treatment guidelines ASAM established.”

By defining one national set of criteria for providing outcome-orientated and results-based care in the treatment of addiction, ASAM’s Patient Placement Criteria is the most widely used and comprehensive set of guidelines for placement. Its new suite of participant interactive journals and eLearning modules will be on display at The Change Companies booth (No. 6) during the conference.

ASAM Board of Director-at-Large Paul Earley, M.D., FASAM, Earley Consultancy, LLC, Atlanta, has participated in the production of ASAM’s Patient Placement Criteria since its first edition. Dr. Earley was tasked with reviewing each of the products developed by The Change Companies to ensure they met ASAM’s high standards, language, and vision for addiction treatment.

“First and foremost, it was important that the products developed by The Change Companies reflected the integrity of, and aligned with, ASAM’s vision for assessment and addiction treatment,” Dr. Earley says. “Our biggest challenge was to make sure the language used in the products, from the workbooks to the website and eLearning modules, matched the language we believe is best used to communicate with patients and train addiction professionals and clinicians.”

The two ASAM Criteria-specific patient journals and two eLearning courses are now available for purchase, Dr. Earley notes, and the ASAM Criteria-specific journals are co-branded. All of the products interface with the ASAM Criteria, Second Edition Revised and ASAM Patient Placement Criteria: Supplement on Pharmacotherapies for Alcohol Use Disorders, which may be ordered at the ASAM Booth in the exhibit hall. The Change Companies CEO Joyce Conley, Ph.D., says the two organizations collaborated to produce thorough and accurate materials.

“Our teams have worked together to create and extensively revise products that address every angle of initial assessment through service planning and continued care,” Dr. Conley says. “We have joined the Patient Placement Criteria with application-focused resources and behavior-change tools and are just beginning to realize the true value such an integration has to offer.”

Additionally, ASAM will conduct a Component Session 9 Town Meeting on the ASAM Criteria Revision (PPC) from 10 a.m. to noon Sunday in Grand Salon East, Salon B, to discuss revisions to the ASAM Criteria. The meeting will address new terminology and updates to the implementation of the ASAM Criteria and the Diagnostic Admission Criteria to keep it compatible with DSM-V of the American Psychiatric Association that will be released in 2013.

“These are some great products that we want everyone to use and be happy with,” Dr. Earley says. “Still, we will continue to screen the products to keep them up to date and effective for the addiction treatment community.”